From Neurological Therapy to a Class-Conditioned Health Resource: The Ketogenic Diet, Food Economics, and Global Inequalities

The ketogenic diet originated as a precisely defined neurological therapy, developed in the early twentieth century for the treatment of refractory epilepsy at a time when pharmacological options were limited.¹ Its rationale was explicitly medical: to induce a metabolic state of ketosis that could modulate neuronal excitability and reduce seizure frequency. In its original formulation, the ketogenic diet was never conceived as a lifestyle, an identity, or a universal model of healthy eating. Its contemporary transformation into a globally promoted dietary paradigm must therefore be understood not only as a biomedical development, but also as a cultural, economic, and political process.

Over the last three decades, ketogenic and broader low-carbohydrate approaches have gained prominence primarily in high-income Western countries, particularly the United States. This rise coincided with a marked deterioration of population metabolic health. In the U.S., approximately 50–55% of total daily caloric intake derives from carbohydrates, with a substantial proportion coming from refined grains and added sugars.² Ultra-processed foods now account for more than half of total caloric consumption in the American diet.³ In this context, ketogenic nutrition has functioned as a corrective intervention—a metabolic counter-model to a food environment shaped by industrial processing, agricultural subsidies, and the large-scale production of inexpensive carbohydrates.

The clinical appeal of ketogenic diets in such settings is therefore unsurprising. Randomized trials and meta-analyses conducted largely in high-income countries demonstrate short-term benefits in weight reduction, glycemic control, and triglyceride levels when ketogenic or very-low-carbohydrate diets are compared with low-fat diets.^4,5 Importantly, these benefits are often observed in populations whose baseline diet is already metabolically detrimental. The ketogenic diet, in this sense, operates less as an extreme intervention and more as a metabolic exit from chronic carbohydrate overconsumption. However, the success of ketogenic diets in Western contexts has contributed to their gradual reframing as a universal model of healthy nutrition. This reframing obscures a critical structural fact: ketogenic diets are expensive, not incidentally, but systematically. Their cost is rooted in the political economy of food.

Globally, carbohydrates represent the cheapest form of dietary energy. Cereals such as rice, wheat, and maize provide the highest caloric yield per unit cost and constitute the dietary foundation for over half of the world’s population.⁶ In low- and middle-income countries (LMICs), carbohydrates often supply more than 60–70% of total daily energy intake.⁷ This pattern is not primarily cultural preference, but a function of food security, price stability, storage capacity, and historical agricultural policy. By contrast, ketogenic diets rely heavily on foods with higher production and distribution costs: animal-source foods, full-fat dairy, fish, and relatively unprocessed fats. Animal protein production requires substantially greater inputs of land, water, feed, and energy per calorie than cereal production.⁸ As a result, meat, eggs, and dairy are consistently more expensive per kilocalorie than staple carbohydrates across both high-income and LMIC settings.⁹

Household expenditure data illustrate this gradient clearly. In high-income countries, wealthier households consume a significantly higher proportion of calories from animal protein and fats, while lower-income households rely more heavily on refined grains and inexpensive carbohydrate-dense foods.¹⁰ Even in the United States, adherence to ketogenic or low-carbohydrate diets correlates strongly with income, education level, and food access. Ketogenic nutrition, therefore, already functions as a stratified health resource within affluent societies. In LMIC contexts, this stratification becomes more pronounced. Average per-capita consumption of animal-source foods remains substantially lower than in high-income countries, often by a factor of three to five.¹¹ For many households, meat and dairy are consumed episodically rather than daily. Transitioning to a ketogenic diet in such environments would require a fundamental reallocation of household resources, often at the expense of overall caloric adequacy or micronutrient diversity.

Crucially, this does not imply that ketogenic diets lack biological relevance in LMIC populations. On the contrary, their efficacy in neurological indications has been demonstrated even in resource-limited settings. Studies of ketogenic therapy for refractory childhood epilepsy in LMICs show meaningful seizure reduction when adequate clinical supervision and dietary adaptation are available.¹¹ These examples underscore an important distinction: ketogenic diets as targeted medical therapies are fundamentally different from ketogenic diets as population-level lifestyle prescriptions. The contemporary low-carbohydrate movement—sometimes described as “low-carb evangelism”—emerged largely as a response to genuine metabolic harm caused by carbohydrate-dominant, ultra-processed food systems.¹² At its best, this movement has played a constructive role in challenging dietary dogma, re-centering insulin resistance in discussions of chronic disease, and advocating for metabolically informed nutrition. Problems arise only when this discourse is detached from economic reality and framed as universally attainable.

When ketogenic diets are presented as a moral or normative ideal of health, their structural inaccessibility risks being misinterpreted as individual failure. This dynamic is particularly problematic in global health contexts. In LMIC settings, where food choice is constrained by price, availability, and political history, dietary restriction is rarely a lifestyle decision; it is an imposed condition. Promoting ketogenic diets without addressing affordability, food systems, and agricultural policy risks deepening nutritional inequities rather than alleviating them.

From a global health perspective, the ketogenic diet thus serves as a revealing case study. Its demonstrated neurological and metabolic benefits highlight what is biologically possible when nutrition is optimized. At the same time, its limited accessibility exposes how contemporary food systems prioritize caloric quantity over metabolic quality. The problem, therefore, is not that ketogenic diets are elitist by design, but that health-promoting nutrition remains structurally expensive. In this sense, ketogenic nutrition should not be dismissed as impractical or ideological. Instead, it can be understood as an indicator of a deeper systemic failure: the inability of global food economies to make metabolically protective diets widely accessible. For LMICs in particular, the challenge is not to import extreme dietary models developed in high-income contexts, but to develop locally grounded, economically viable strategies that improve metabolic health without undermining food security.

In conclusion, the ketogenic diet remains a legitimate and powerful therapeutic tool, especially in neurology, with expanding relevance to metabolic and psychiatric disorders.^13,14 Its uneven global accessibility reflects broader political and economic structures rather than intrinsic limitations of the diet itself. Recognizing this distinction allows ketogenic nutrition to be discussed not as a universal prescription, but as a lens through which global inequalities in health, food, and metabolic risk become visible.

Conflict of Interest Statement

The author declares no conflict of interest.

Funding statement

The author did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sectors.